The clinical impact of circulating caspase-3 p17 level: a potential new biomarker for myocardial injury and cardiovascular disease

Author： Singh Kanwar P   Jaffe Allan S   Liang Bruce T  

Publisher： Future Medicine

ISSN： 1479-6678

Source： Future Cardiology, Vol.7, Iss.4, 2011-07, pp. : 443-445

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Circulating cellular adhesion molecules ICAM-1, VCAM-1, P- and E-selectin in the prediction of cardiovascular disease in diabetes mellitus

By Jude E.B.   Douglas J.T.   Anderson S.G.   Young M.J.   Boulton A.J.M.  

European Journal of Internal Medicine, Vol. 13, Iss. 3, 2002-05 ,pp. : 185-189

Elsevier

Access to resources Recommend Favorite

The Cardioprotective Potential of Bosentan in Myocardial Ischemia Reperfusion Injury

By  

World Heart Journal, Vol. , Iss. , 2017-01 ,pp. : 69-78

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Adrenomedullins: Therapeutic Potential in Cardiovascular Disease

By  

Current Hypertension Reviews, Vol. 7, Iss. 4, 2011-12 ,pp. : 284-291

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Thiazolidinediones as PPAR&ggr; Ligands with the Potential for the Prevention of Cardiovascular Disease in Diabetes

By  

Current Diabetes Reviews, Vol. 2, Iss. 2, 2006-05 ,pp. : 227-239

Bentham Science Publishers

Access to resources Recommend Favorite

Pregnancy-Associated Plasma Protein-A and its Role in Cardiovascular Disease. Biology, Experimental/Clinical Evidences and Potential Therapeutic Approaches

By  

Current Vascular Pharmacology, Vol. 15, Iss. 3, 2017-04 ,pp. : 197-206

Bentham Science Publishers

Access to resources Recommend Favorite